Tag: biotechnology
-
Start-Up Developing Immunometabolism Therapies, Gains $30M Funding
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells.
-
Trials to Test Stem Cell Treatments for Eye Injuries
A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss.
-
Biotech in $3.7B Licensing Deal for Hepatitis-B
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals.
-
Jet Fuel from Carbon Waste Powers Virgin Atlantic Flight
A Virgin Atlantic flight arriving earlier today from Orlando, Florida to London’s Gatwick airport is the first to use a biofuel made from fermented carbon-rich industrial waste gases.
-
Human Antibodies Devised for Snakebite Treatment
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake.
-
Protein Delivered with Gold Nanoparticles Helps Fix Muscle Injuries
A bioengineering lab at Harvard University devised a technique using gold nanoscale particles to deliver a protein to reduce inflammation from muscle injuries in lab mice.
-
Genome Editing Offers Marketable Wild Tomato
The groundcherry, a wild tomato plant that its devotees say has a delicious and unusual flavor, could be grown on farms for sale to consumers thanks to a genome editing project at two New York research institutes.
-
Antibody Combination Shown to Suppress HIV
Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy.
-
Synthetic Antibody Neutralizing Gluten in Development
An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten.
-
Spin-Off Company Developing New Antibiotics
A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections.